2023 Annual Meeting | C142 - Neuro-oncology: Navigating Current Trends

Date Tuesday 04/25/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Wendy Sherman, MD

Topic(s) Neuro-oncology

Learning Objectives Participants will have increased knowledge regarding key clinical trial evidence supporting advancements in the treatment of primary and secondary central nervous system tumors, and integrate emerging evidence into treatment paradigms for patients with primary and secondary central nervous system tumors.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:00 PM EST	Speaker	Updates on Primary CNS Tumors Michael W. Ruff, MD
04:00 PM - 04:30 PM EST	Speaker	Contemporary Approach to Metastatic Disease in the CNS Tobias Walbert, MD, PhD, FAAN
04:30 PM - 05:00 PM EST	Speaker	Case Studies Wendy Sherman, MD
05:00 PM - 05:30 PM EST	Discussion	Questions and Answers Wendy Sherman, MD, Michael W. Ruff, MD, Tobias Walbert, MD, PhD, FAAN

Faculty Disclosures
Wendy Sherman, MD	Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Michael W. Ruff, MD	Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.